[{"_id":"556499bbfac443afdd39367c","決算期":"---","証券コード":"4579","会社名":"ラクオリア創薬(株)【4579】","会計方式":"---","決算発表日":"---","決算月数":"---","売上高":"---","営業利益":"---","経常利益":"---","当期利益":"---","EPS（一株当たり利益）":"円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"---","総資産":"---","自己資本":"---","資本金":"---","有利子負債":"---","自己資本比率":"---","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","日付":"2015-05-31T15:38:20.616Z"},{"_id":"556499bbfac443afdd39367d","決算期":"2014年12月期","証券コード":"4579","会社名":"ラクオリア創薬(株)【4579】","会計方式":"日本方式","決算発表日":"2015年2月13日","決算月数":"12か月","売上高":"153百万円","営業利益":"-2,183百万円","経常利益":"-2,116百万円","当期利益":"-638百万円","EPS（一株当たり利益）":"-45.70円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"314.66円","総資産":"5,216百万円","自己資本":"4,675百万円","資本金":"8,952百万円","有利子負債":"140百万円","自己資本比率":"89.6%","ROA（総資産利益率）":"-10.76%","ROE（自己資本利益率）":"-12.28%","総資産経常利益率":"-35.67%","日付":"2015-05-31T15:38:20.616Z"},{"_id":"556499bbfac443afdd39367e","決算期":"2013年12月期","証券コード":"4579","会社名":"ラクオリア創薬(株)【4579】","会計方式":"日本方式","決算発表日":"2014年2月14日","決算月数":"12か月","売上高":"228百万円","営業利益":"-2,137百万円","経常利益":"-1,819百万円","当期利益":"-1,108百万円","EPS（一株当たり利益）":"-82.70円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"423.84円","総資産":"6,648百万円","自己資本":"5,713百万円","資本金":"8,627百万円","有利子負債":"---","自己資本比率":"85.9%","ROA（総資産利益率）":"-16.67%","ROE（自己資本利益率）":"-19.39%","総資産経常利益率":"-27.36%","日付":"2015-05-31T15:38:20.616Z"}]